$SIGA
SIGA Technologies Inc Stock $siga

$siga Overview Financials Valuation SEC Filings Company Website

2017 Q3 Form 10-Q Financial Statement

#000101008617000012 Filed on November 07, 2017

Income Statement

Concept	2017 Q3	2016 Q3
Revenue	$1.390M	$4.700M
YoY Change	-70.43%	261.54%
Cost Of Revenue	$0.00
YoY Change
Gross Profit	$1.390M
YoY Change
Gross Profit Margin	100.0%
Selling, General & Admin	$3.094M	$2.855M
YoY Change	8.37%	23.01%
% of Gross Profit	222.59%
Research & Development	$2.471M	$6.069M
YoY Change	-59.28%	150.06%
% of Gross Profit	177.77%
Depreciation & Amortization	$29.38K	$42.66K
YoY Change	-31.14%	-18.42%
% of Gross Profit	2.11%
Operating Expenses	$7.041M	$12.72M
YoY Change	-44.65%	156.68%
Operating Profit	-$5.651M	-$8.062M
YoY Change	-29.91%	122.15%
Interest Expense	$3.737M	$94.78K
YoY Change	3843.17%
% of Operating Profit
Other Income/Expense, Net	$2.021K	$30.76K
YoY Change	-93.43%	146.38%
Pretax Income	$9.700M	$9.200M
YoY Change	5.43%	64.29%
Income Tax	$134.7K	-$4.072K
% Of Pretax Income	1.39%	-0.04%
Net Earnings	-$9.816M	-$9.244M
YoY Change	6.19%	64.16%
Net Earnings / Revenue	-706.19%	-196.68%
Basic Earnings Per Share	-$0.12
Diluted Earnings Per Share	-$0.12	-$169.4K
COMMON SHARES
Basic Shares Outstanding	78.91M shares	53.87M shares
Diluted Shares Outstanding	78.91M shares

Balance Sheet

Concept	2017 Q3	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$25.80M	$20.50M
YoY Change	25.85%	-84.15%
Cash & Equivalents	$25.80M	$20.49M
Short-Term Investments
Other Short-Term Assets	$11.50M	$9.600M
YoY Change	19.79%	17.07%
Inventory	$2.983M	$17.75M
Prepaid Expenses
Receivables	$612.2K	$38.75M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$40.89M	$86.58M
YoY Change	-52.77%	-37.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$119.7K	$330.1K
YoY Change	-63.73%	-27.84%
Goodwill	$898.3K	$898.3K
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$642.1K	$642.1K
YoY Change	0.0%	-67.73%
Total Long-Term Assets	$107.8M	$76.26M
YoY Change	41.4%	32.27%
TOTAL ASSETS
Total Short-Term Assets	$40.89M	$86.58M
Total Long-Term Assets	$107.8M	$76.26M
Total Assets	$148.7M	$162.8M
YoY Change	-8.67%	-17.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.362M	$2.925M
YoY Change	-53.43%	-7.85%
Accrued Expenses	$4.321M	$4.793M
YoY Change	-9.85%	56.47%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$13.04M	$108.3M
YoY Change	-87.96%	1636.51%
LONG-TERM LIABILITIES
Long-Term Debt	$69.90M	$0.00
YoY Change
Other Long-Term Liabilities	$378.3M	$367.4M
YoY Change	2.97%	-18.01%
Total Long-Term Liabilities	$448.2M	$367.4M
YoY Change	21.99%	-18.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.04M	$108.3M
Total Long-Term Liabilities	$448.2M	$367.4M
Total Liabilities	$461.6M	$476.0M
YoY Change	-3.04%	3.07%
SHAREHOLDERS EQUITY
Retained Earnings	-$527.1M	-$490.7M
YoY Change	7.41%	11.18%
Common Stock	$214.2M	$177.5M
YoY Change	20.68%	0.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$312.8M	-$313.2M
YoY Change
Total Liabilities & Shareholders Equity	$148.7M	$162.8M
YoY Change	-8.67%	-17.41%

Cashflow Statement

Concept	2017 Q3	2016 Q3
OPERATING ACTIVITIES
Net Income	-$9.816M	-$9.244M
YoY Change	6.19%	64.16%
Depreciation, Depletion And Amortization	$29.38K	$42.66K
YoY Change	-31.14%	-18.42%
Cash From Operating Activities	-$7.620M	-$56.23M
YoY Change	-86.45%	-510.44%
INVESTING ACTIVITIES
Capital Expenditures	-$10.00K	$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities	-$10.00K	$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	-1.290M
YoY Change	-100.0%
NET CHANGE
Cash From Operating Activities	-7.620M	-56.23M
Cash From Investing Activities	-10.00K	0.000
Cash From Financing Activities	0.000	-1.290M
Net Change In Cash	-7.630M	-57.52M
YoY Change	-86.74%	-521.7%
FREE CASH FLOW
Cash From Operating Activities	-$7.620M	-$56.23M
Capital Expenditures	-$10.00K	$0.00
Free Cash Flow	-$7.610M	-$56.23M
YoY Change	-86.47%	-508.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001010086
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	78908929	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	SIGA TECHNOLOGIES INC
	dei	Trading Symbol TradingSymbol	SIGAQ
CY2011Q2	siga	Amountofoptiontobereceivedfrom Bard Aforapprovalforextensionof84mothexpiry AmountofoptiontobereceivedfromBARDAforapprovalforextensionof84mothexpiry	50000000	USD
CY2016Q4	siga	Computer Equipment ComputerEquipment	770479	USD
CY2017Q3	siga	Computer Equipment ComputerEquipment	655880	USD
CY2011Q2	siga	Contract Value Detail Of Option Exercisable Development Activities ContractValueDetailOfOptionExercisableDevelopmentActivities	58300000	USD
CY2011Q2	siga	Contract Value Detail Of Option Exercisable Production Activities ContractValueDetailOfOptionExercisableProductionActivities	14400000	USD
CY2011Q2	siga	Contract Value Option Fda Approval ContractValueOptionFDAApproval	50000000	USD
CY2011Q2	siga	Contract Valueof Various Options ContractValueofVariousOptions	122700000	USD
	siga	Decrease In Fair Value Of Warrants DecreaseInFairValueOfWarrants	-1121530	USD
	siga	Decrease In Fair Value Of Warrants DecreaseInFairValueOfWarrants	-627624	USD
CY2016Q3	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	1121530	USD
	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	1121530	USD
CY2017Q3	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	295771	USD
	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	627624	USD
	siga	Increasedecreasein Pharm Atheneliability IncreasedecreaseinPharmAtheneliability	93654855	USD
	siga	Increasedecreasein Pharm Atheneliability IncreasedecreaseinPharmAtheneliability	0	USD
CY2017Q3	siga	Increaseto Fundingof Researchand Development Contract IncreasetoFundingofResearchandDevelopmentContract	10100000	USD
	siga	Interest Paidon Term Loan From Restricted Cash InterestPaidonTermLoanFromRestrictedCash	0	USD
	siga	Interest Paidon Term Loan From Restricted Cash InterestPaidonTermLoanFromRestrictedCash	7633396000	USD
	siga	Inventory Write Downs InventoryWriteDowns	686000	USD
	siga	Number Of Active Grants NumberOfActiveGrants	1	grant
CY2016Q3	siga	Patent Preparation Fees PatentPreparationFees	230246	USD
	siga	Patent Preparation Fees PatentPreparationFees	689651	USD
CY2017Q3	siga	Patent Preparation Fees PatentPreparationFees	250857	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	siga	Patent Preparation Fees PatentPreparationFees	688471	USD
	siga	Paymentof Interest Expense PaymentofInterestExpense	0	USD
	siga	Paymentof Interest Expense PaymentofInterestExpense	-7633396	USD
CY2017Q3	siga	Potential Future Aggregate Research And Development Expenses PotentialFutureAggregateResearchAndDevelopmentExpenses	15400000	USD
CY2016	siga	Reducedholdbackamount Reducedholdbackamount	40900000	USD
	siga	Reorganization Payments ReorganizationPayments	4600000	USD
	siga	Reorganization Professional Fees ReorganizationProfessionalFees	1732521	USD
	siga	Reorganization Trusteefees ReorganizationTrusteefees	33000	USD
CY2016Q3	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	4658355	USD
	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	7829402	USD
CY2017Q3	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	1390254	USD
	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	10856601	USD
CY2017Q3	siga	Researchand Development Revenue Longterm Contract ResearchandDevelopmentRevenueLongtermContract	600000	USD
	siga	Researchand Development Revenue Longterm Contract ResearchandDevelopmentRevenueLongtermContract	8300000	USD
	siga	Restricted Stock Units RestrictedStockUnits	313337	shares
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2517072	USD
CY2017Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1362331	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3154370	USD
CY2017Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	612166	USD
CY2016Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2357194	USD
CY2017Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1676745	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4584752	USD
CY2017Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4320994	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	481641	USD
CY2017Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	661194	USD
CY2016Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	262664	USD
CY2017Q3	us-gaap	Accrued Vacation Current AccruedVacationCurrent	333675	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3468266	USD
CY2017Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3319761	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	213714154	USD
CY2017Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	214238249	USD
CY2016Q4	us-gaap	Assets Assets	160981977	USD
CY2017Q3	us-gaap	Assets Assets	148726158	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	69159474	USD
CY2017Q3	us-gaap	Assets Current AssetsCurrent	40894746	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	112711028	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20492788	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28701824	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25798125	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-92218240	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2903699	USD
CY2016Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.29
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	78692612	shares
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	78908929	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78692612	shares
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78908929	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	7869	USD
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	7890	USD
CY2017Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	134668	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	342563	USD
	us-gaap	Debtor Reorganization Items Legal And Advisory Professional Fees DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees	1951381	USD
CY2016Q4	us-gaap	Deferred Costs DeferredCosts	72649277	USD
CY2017Q3	us-gaap	Deferred Costs DeferredCosts	96741244	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	111865203	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	9963188	USD
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	367483905	USD
CY2017Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	377447093	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	286066	USD
CY2017Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	306449	USD
CY2016Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	42660	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	130704	USD
CY2017Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	29375	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	105212	USD
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.54
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.12
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.33
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	627624000	USD
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	6727409000	USD
CY2017Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7355033000	USD
CY2016Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	455220	USD
CY2017Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	363588	USD
CY2016Q3	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	USD
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	USD
CY2017Q3	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-1225421	USD
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-1225421	USD
CY2016Q4	us-gaap	Goodwill Goodwill	898334	USD
CY2017Q3	us-gaap	Goodwill Goodwill	898334	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	9700000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	25600000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9247714	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-29249368	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9681710	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-25590198	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	385680	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4072	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8692	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	134668	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	342563	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1719229	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	35070347	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2542204	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	21452562	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	24091967	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	16246	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	20383	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5304431	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-22690715	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1347437	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-63171	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-199501	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1835322	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	137970	USD
CY2016Q3	us-gaap	Interest Expense InterestExpense	94776	USD
	us-gaap	Interest Expense InterestExpense	104991	USD
CY2017Q3	us-gaap	Interest Expense InterestExpense	3737175	USD
	us-gaap	Interest Expense InterestExpense	10995900	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7293880	USD
CY2017Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	957804	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	26209964	USD
CY2017Q3	us-gaap	Inventory Net InventoryNet	2983249	USD
CY2016Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	18916084	USD
CY2017Q3	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	2025445	USD
	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2017Q3	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
	us-gaap	Inventory Write Down InventoryWriteDown	536000	USD
CY2016Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2542044	USD
CY2017Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2420028	USD
CY2016Q4	us-gaap	Liabilities Liabilities	448400246	USD
CY2017Q3	us-gaap	Liabilities Liabilities	461553072	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	160981977	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	148726158	USD
CY2017Q3	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	-5832624	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13829233	USD
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	13038358	USD
	us-gaap	Liabilities Subject To Compromise Expense Reversal Of Expense For Liabilities LiabilitiesSubjectToCompromiseExpenseReversalOfExpenseForLiabilities	-206972170	USD
	us-gaap	Liabilities Subject To Compromise Expense Reversal Of Expense For Liabilities LiabilitiesSubjectToCompromiseExpenseReversalOfExpenseForLiabilities	0	USD
CY2016Q3	us-gaap	Litigation Settlement Interest LitigationSettlementInterest	3566451	USD
	us-gaap	Litigation Settlement Interest LitigationSettlementInterest	10716276	USD
CY2017Q3	us-gaap	Litigation Settlement Interest LitigationSettlementInterest	0	USD
	us-gaap	Litigation Settlement Interest LitigationSettlementInterest	0	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	66553053	USD
CY2017Q3	us-gaap	Long Term Debt LongTermDebt	69916765	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1294501	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-249555	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10997	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-54242	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-90912742	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2599902	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-9243642	USD
	us-gaap	Net Income Loss NetIncomeLoss	-29258060	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-9816378	USD
	us-gaap	Net Income Loss NetIncomeLoss	-25932761	USD
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	30756	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	100556	USD
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2021	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	11818	USD
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	12720519	USD
	us-gaap	Operating Expenses OperatingExpenses	32235903	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	7041039	USD
	us-gaap	Operating Expenses OperatingExpenses	24835093	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8062164	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-24406501	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5650785	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13978492	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1483253	USD
CY2017Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1649380	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	642083	USD
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	642083	USD
CY2016Q4	us-gaap	Other Liabilities OtherLiabilities	247989	USD
CY2017Q3	us-gaap	Other Liabilities OtherLiabilities	844407	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	0	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	3363712	USD
CY2016Q4	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	217000000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	84000	USD
	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts	1294501	USD
	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts		USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	193052	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10997	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	54242	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	954426	USD
CY2017Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1092396	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	27497	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3767743	USD
CY2017Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3439496	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	299477	USD
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	119735	USD
CY2016Q3	us-gaap	Reorganization Items ReorganizationItems	0	USD
	us-gaap	Reorganization Items ReorganizationItems	3716902	USD
CY2017Q3	us-gaap	Reorganization Items ReorganizationItems	0	USD
	us-gaap	Reorganization Items ReorganizationItems	0	USD
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6068567	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11553469	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2470835	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13899162	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	10138890	USD
CY2017Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	10408810	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	17333332	USD
CY2017Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	9430016	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-501140292	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-527073053	USD
CY2016Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2855255	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9276507	USD
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3093926	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9022039	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	521666	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	773671	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-287418269	USD
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	-312826914	USD
CY2016Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	6727409	USD
CY2017Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	7355033	USD
CY2016Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	54284296	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	54205354	shares
CY2017Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	78908929	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	78842611	shares

Files In Submission

Name	View Source	Status
0001010086-17-000012-index-headers.html	Edgar Link	pending
0001010086-17-000012-index.html	Edgar Link	pending
0001010086-17-000012.txt	Edgar Link	pending
0001010086-17-000012-xbrl.zip	Edgar Link	pending
a102image.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
siga-20170930.xml	Edgar Link	completed
siga-20170930.xsd	Edgar Link	pending
siga-20170930x10q.htm	Edgar Link	pending
siga-20170930_cal.xml	Edgar Link	unprocessable
siga-20170930_def.xml	Edgar Link	unprocessable
siga-20170930_lab.xml	Edgar Link	unprocessable
siga-20170930_pre.xml	Edgar Link	unprocessable
siga-exhibit1012017q3.htm	Edgar Link	pending
siga-exhibit102leaseaggrem.htm	Edgar Link	pending
siga-exhibit3112017q3.htm	Edgar Link	pending
siga-exhibit3122017q3.htm	Edgar Link	pending
siga-exhibit3212017q3.htm	Edgar Link	pending
siga-exhibit3222017q3.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SIGA
SIGA Technologies Inc Stock $siga

2017 Q3 Form 10-Q Financial Statement

#000101008617000012 Filed on November 07, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA SIGA Technologies Inc Stock $siga

2017 Q3 Form 10-Q Financial Statement

#000101008617000012 Filed on November 07, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA
SIGA Technologies Inc Stock $siga